<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-06-29T07:25:13Z</responseDate><request verb="GetRecord" identifier="oai:docta.ucm.es:20.500.14352/19242" metadataPrefix="oai_dc">https://docta.ucm.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:docta.ucm.es:20.500.14352/19242</identifier><datestamp>2024-07-31T14:59:38Z</datestamp><setSpec>com_20.500.14352_14</setSpec><setSpec>col_20.500.14352_15</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways</dc:title>
   <dc:creator>Olmedo, Dionisio A.</dc:creator>
   <dc:creator>López-Pérez, José Luis</dc:creator>
   <dc:creator>del Olmo, Esther</dc:creator>
   <dc:creator>Bedoya Del Olmo, Luis Miguel</dc:creator>
   <dc:creator>Sancho, Rocío</dc:creator>
   <dc:creator>Alcamí, José</dc:creator>
   <dc:creator>Muñoz, Eduardo</dc:creator>
   <dc:creator>San Feliciano, Arturo</dc:creator>
   <dc:creator>Gupta, Mahabir P.</dc:creator>
   <dc:subject>615.011</dc:subject>
   <dc:subject>Neoflavonoids</dc:subject>
   <dc:subject>4-phenyl-chromen-one</dc:subject>
   <dc:subject>AIDS</dc:subject>
   <dc:subject>Tat protein</dc:subject>
   <dc:subject>NF-κB inhibition</dc:subject>
   <dc:subject>Anti-HIV activity</dc:subject>
   <dc:subject>Farmacología (Farmacia)</dc:subject>
   <dc:subject>Química farmaceútica</dc:subject>
   <dc:subject>3209 Farmacología</dc:subject>
   <dc:subject>2390 Química Farmacéutica</dc:subject>
   <dc:description>Twenty-eight neoflavonoids have been prepared and evaluated in vitro against HIV-1. Antiviral activity was assessed on MT-2 cells infected with viral clones carrying the luciferase reporter gene. Inhibition of HIV transcription and Tat function were tested on cells stably transfected with the HIV-LTR and Tat protein. Seven 4-phenylchromen-2 one derivatives showed HIV transcriptional inhibitory activity but only the phenylchrome-2-one 10 inhibited NF-κB and displayed anti-Tat activity simultaneously. Compounds 10, 14, and 25, inhibited HIV replication in both targets at concentrations &lt;25 µM. The assays of these synthetic 4 phenylchromen-2-ones may aid in the investigation of some aspects of the anti-HIV activity of such compounds and could serve as a scaffold for designing better anti-HIV compounds, which may lead to a potential anti-HIV therapeutic drug.</dc:description>
   <dc:description>Ministerio de Economía, Comercio y Empresa (España)/Instituto de Salud Carlos III/Fondo Europeo de Desarrollo Regional</dc:description>
   <dc:description>Instituto de Salud Carlos III/Fondo Europeo de Desarrollo Regional</dc:description>
   <dc:description>Depto. de Farmacología, Farmacognosia y Botánica</dc:description>
   <dc:description>Fac. de Farmacia</dc:description>
   <dc:description>TRUE</dc:description>
   <dc:description>pub</dc:description>
   <dc:date>2023-06-18T00:05:44Z</dc:date>
   <dc:date>2023-06-18T00:05:44Z</dc:date>
   <dc:date>2017-02-19</dc:date>
   <dc:type>journal article</dc:type>
   <dc:identifier>https://hdl.handle.net/20.500.14352/19242</dc:identifier>
   <dc:identifier>1420-3049</dc:identifier>
   <dc:identifier>10.3390/molecules22020321</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>PI16/CIII/034</dc:relation>
   <dc:relation>RD16CIII/0002/0001</dc:relation>
   <dc:relation>Olmedo, D. A., López-Pérez, J. L., Del Olmo, E. et al. «Neoflavonoids as Inhibitors of HIV-1 Replication by Targeting the Tat and NF-κB Pathways». Molecules, vol. 22, n.o 2, febrero de 2017, p. 321. DOI.org (Crossref), https://doi.org/10.3390/molecules22020321.</dc:relation>
   <dc:rights>Atribución 3.0 España</dc:rights>
   <dc:rights>https://creativecommons.org/licenses/by/3.0/es/</dc:rights>
   <dc:rights>open access</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>MDPI</dc:publisher>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>